Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Using annuities and stocks for retirement income explains blending these assets to diversify risk and stabilize cash flow for retirement.
28,656 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Mortgage rates surge past 6.7% as bond markets wobble and geopolitics stoke inflation fears. Borrowers and lenders ad...
Meta AI projects a Bitcoin breakout by summer 2026, with targets near or above $100K. The call hinges on technical se...
Strategy shifted roughly 411 BTC to Coinbase Prime, prompting a fresh look at its cash strategy. The move has revived...
Dayton, Ohio pauses its ALPR program as privacy concerns rise. ohio city workers covering the cameras have put 72 dev...
Lenders roll out alt-score models while the secondary mortgage market waits for performance data, prompting rating ag...
As a new Fed leadership team takes the reins, investors are bracing for a steadier communications stance. Analysts sa...
January CPI shows inflation cooled a notch but remains elevated, keeping policy expectations in focus and households ...
A federal watchdog report finds a notable denial rate for prior authorizations in Medicare Advantage plans, with wide...
Ripple faces a pivotal week as XRP tests critical support near $1 and resistance at $1.40. Analysts publish ripple (x...
A Wall Street Journal probe alleges polymarket used staged bets to fuel viral growth, prompting questions about trans...